Your browser doesn't support javascript.
loading
Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicentre study of the Italian Melanoma Intergroup (IMI).
Mandalà, Mario; Galli, Francesca; Patuzzo, Roberto; Maurichi, Andrea; Mocellin, Simone; Rossi, Carlo R; Rulli, Eliana; Montesco, Maria; Quaglino, Pietro; Caliendo, Virginia; De Giorgi, Vincenzo; Merelli, Barbara; Caracò, Corrado; Piazzalunga, Dario; Labianca, Alice; Ribero, Simone; Senetta, Rebecca; Gianatti, Andrea; Valeri, Barbara; Massi, Daniela; Ascierto, Paolo A; Santinami, Mario.
Afiliação
  • Mandalà M; Unit of Medical Oncology, Papa Giovanni XXIII Hospital, Bergamo, Italy. Electronic address: mmandala@asst-pg23.it.
  • Galli F; Methodology for Clinical Research Laboratory, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
  • Patuzzo R; Melanoma and Sarcoma Unit, Department of Surgery, IRCCS Fondazione Istituto Nazionale dei Tumori, Milan, Italy.
  • Maurichi A; Melanoma and Sarcoma Unit, Department of Surgery, IRCCS Fondazione Istituto Nazionale dei Tumori, Milan, Italy.
  • Mocellin S; Unit of Surgery, Veneto Institute of Oncology - IOV.
  • Rossi CR; University of Padua, Italy.
  • Rulli E; Methodology for Clinical Research Laboratory, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
  • Montesco M; Pathological Anatomy and Histology, Veneto Institute of Oncology - IOV, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy.
  • Quaglino P; Dermatologic Clinic, Department of Medical Sciences, University of Turin Medical School, Turin, Italy.
  • Caliendo V; Department of Surgery, University of Turin Madical Scholl.
  • De Giorgi V; Department of Dermatology, University of Florence, Italy.
  • Merelli B; Unit of Medical Oncology, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Caracò C; Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Naples, Italy.
  • Piazzalunga D; Unit of Surgery, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Labianca A; Unit of Medical Oncology, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Ribero S; Dermatologic Clinic, Department of Medical Sciences, University of Turin Medical School, Turin, Italy.
  • Senetta R; Pathology Division, 'Città della Salute e della Scienza di Torino' University Hospital, Turin, Italy.
  • Gianatti A; Unit of Pathology, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Valeri B; Department of Pathology and Laboratory Medicine, IRCCS Fondazione Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Massi D; Histopatology and Molecular Diagnostics, Careggi University Hospital, Florence, Italy.
  • Ascierto PA; Unit Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Naples, Italy.
  • Santinami M; Melanoma and Sarcoma Unit, Department of Surgery, IRCCS Fondazione Istituto Nazionale dei Tumori, Milan, Italy.
Eur J Cancer ; 137: 30-39, 2020 09.
Article em En | MEDLINE | ID: mdl-32739767
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Eur J Cancer Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Eur J Cancer Ano de publicação: 2020 Tipo de documento: Article